Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leroy

Showing results (61-70 of 663) with videos related to

Pageof 67
Sort By:
Microvascular Research|July 1, 1976
Human alveolar basement membrane. Chemical and immunologic comparisons with glomerular basement membrane and trophoblast basement membraneB A Bray, E C LeRoy
Clinics in Dermatology|July 1, 1994
Cytokines and systemic sclerosisD M Fagundus, E C Leroy
Comprehensive Therapy|February 1, 1981
Raynaud's phenomenon and sclerodermaF E Harper, E C LeRoy
Thrombosis Research|May 15, 1994
Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurementsC Leroy-Matheron, M Gouault-Heilmann
Clinical and Experimental Rheumatology|July 1, 1990
The changing face of severe scleroderma in five patientsM S Spooner, E C LeRoy
Bulletin on the Rheumatic Diseases|October 1, 1996
Paul Klee and sclerodermaE C LeRoy, R M Silver
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|September 1, 1981
[Comparison of the waking EEG with the subjective impressions of the waking individual (author's transl)]M Hedouin, T Lagrange, C Leroy
Soins. Chirurgie (Paris, France : 1982)|June 1, 1987
[The social readjustment of burn victims]C Leroy, M Beck, M Martin
Annals of the Rheumatic Diseases|July 16, 2002
A profibrotic polymorphism (of TGFbeta1) in systemic sclerosisJ P Pandey, E C LeRoy
Annals of Internal Medicine|March 15, 1989
Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease durationM B Kahaleh, E C LeRoy
Pageof 67

Showing results (61-70 of 663) with videos related to

Sort By:
Pageof 67
Microvascular Research|July 1, 1976
Human alveolar basement membrane. Chemical and immunologic comparisons with glomerular basement membrane and trophoblast basement membraneB A Bray, E C LeRoy
Clinics in Dermatology|July 1, 1994
Cytokines and systemic sclerosisD M Fagundus, E C Leroy
Comprehensive Therapy|February 1, 1981
Raynaud's phenomenon and sclerodermaF E Harper, E C LeRoy
Thrombosis Research|May 15, 1994
Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurementsC Leroy-Matheron, M Gouault-Heilmann
Clinical and Experimental Rheumatology|July 1, 1990
The changing face of severe scleroderma in five patientsM S Spooner, E C LeRoy
Bulletin on the Rheumatic Diseases|October 1, 1996
Paul Klee and sclerodermaE C LeRoy, R M Silver
Revue D'Electroencephalographie Et De Neurophysiologie Clinique|September 1, 1981
[Comparison of the waking EEG with the subjective impressions of the waking individual (author's transl)]M Hedouin, T Lagrange, C Leroy
Soins. Chirurgie (Paris, France : 1982)|June 1, 1987
[The social readjustment of burn victims]C Leroy, M Beck, M Martin
Annals of the Rheumatic Diseases|July 16, 2002
A profibrotic polymorphism (of TGFbeta1) in systemic sclerosisJ P Pandey, E C LeRoy
Annals of Internal Medicine|March 15, 1989
Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease durationM B Kahaleh, E C LeRoy
Pageof 67